Laura Donnelly

Laura Donnelly is Health Editor at The Telegraph, focused on how NHS policy, funding decisions and new treatments affect patient care on the ground. Her coverage connects internal health-service reforms, clinical evidence and real-world outcomes, often using exclusives and investigations to expose consequences that are not visible in official messaging. She combines hard news, data-led stories and scientific reporting to track both crises and advances across the health system.

NHS policy, pressure and reform

Donnelly’s core work sits on the workings and pressures of the NHS, from structural reforms to day-to-day failures in care. Her reporting has uncovered fundamental changes to GP access, including central instructions to embed “total triage” systems that force patients through remote consultations before they can see a doctor face to face. She has investigated maternity safety, exposing soaring maternity blunders and deaths linked to pilot A&E triage schemes.

Ambulance performance is another recurring theme, with scoops showing urgent calls being secretly delayed and the impact this has on emergency outcomes. Across these stories she translates complex health policy into direct, news-led pieces, with a clear preference for plain language over jargon. Recent work highlighted NHS waiting lists and strikes, treating them as symptoms of longer-running structural pressures rather than isolated disputes.

She also returns to questions of accountability and governance, examining how official guidance, internal targets and political promises play out in routine care.

Screening, cancer and men’s health

Donnelly devotes sustained attention to screening policy and cancer detection, particularly around prostate cancer. One line of coverage scrutinises NHS prostate cancer strategies, warning that flawed plans risk missing cases and exploring where proposed pathways diverge from best practice. Another focuses on calls for national prostate cancer screening, including pieces on political pushes for a formal programme and the capacity and funding implications inside the NHS. Her author archive also includes stories on NHS-backed programmes offering men rapid access to new treatments, framed in terms of securing longer and healthier lives rather than simply rolling out new drugs. Across this strand she writes about the trade-offs between early detection, resource constraints and the danger that policy shortcuts or poorly designed pilots leave dangerous gaps in care.

Weight-loss drugs, diabetes and prevention

Donnelly regularly reports on the fast-growing use of injectable weight-loss and diabetes drugs and what they mean for NHS budgets and prevention policy. Her coverage has detailed how new medicines such as Mounjaro and Ozempic have helped drive a doubling in NHS spending on diabetes treatments over a decade, using prescribing statistics to show the scale of change. She explains the dual role of these drugs, originally developed for diabetes but now central to weight-management strategies, and the difficulty of separating spend on metabolic disease from spend on obesity when reading national figures. In related pieces she looks at NHS-backed prevention programmes and lifestyle interventions, setting weight-loss jabs against broader efforts to reduce diabetes risk through behaviour change. Her reporting on weight-loss schemes emphasises access routes, eligibility criteria and the balance between clinical benefit, cost-effectiveness and public demand.

Pandemic fallout and wider public health

Donnelly’s work on Covid-19 and its aftermath has been central to her profile, spanning government strategy, testing, vaccination and collateral damage. Early in the pandemic she revealed plans for “stay home” policies and the abandonment of widespread testing weeks before they were officially announced, showing how internal decisions reshaped national strategy. She followed the consequences of testing failures, documenting how gaps in capacity and policy missteps fed through into excess risk for patients and staff. Her reporting also tracked the rollout of the first Covid jabs and the acceleration of the vaccine programme ahead of “freedom day”, balancing the promise of mass immunisation against operational realities.

Beyond Covid, she covers spikes in mental-health demand, including a recent piece on NHS referrals for anxiety rising by a third since the pandemic, which links access pressures to longer-term societal stress. Public health crises remain a live strand: she has written on meningitis outbreaks, including the race to stop nationwide spread after a deadly cluster and the delays in tackling the initial cases. Alongside these stories she brings in biomedical and vaccine breakthroughs, often highlighting how new technologies move from research to frontline use.

In format terms her work is predominantly news-driven, filed for the daily and Sunday editions as well as online, mixing diary coverage from journals and conferences with exclusives and occasional features or video.